3rd generation glp-1 LY3437943, a novel triple glucagon, GIP, and receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Companies are racing to improve

Regulatory Toxicology and Pharmacology, 153 , 105715

Do not double the next dose to compensate

For example, Ozempic arguably the GLP-1 medication with the most name recognition hasnt been approved by the FDA for weight loss management, nor has the medication Mounjaro

doi: 10.1016/J.CANLET.2024.216894 124 LiYLiuFCaiQDengLOuyangQZhangXHFet al

These strategies aim to address different aspects of metabolic dysfunction while building on the proven benefits of incretin-based therapy

The following are considered non-clear fluids : Milk* and cream (including in tea or coffee) Non-dairy whiteners such as almond, soy, or oat milk Soluble fibre Broths Jelly *Breast milk can be given up to 3 hours before the procedure